Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis
暂无分享,去创建一个
F. Barkhof | M. Filippi | L. Kappos | C. Polman | D. Knol | F. Fazekas | B. Uitdehaag | K. Wagner | C. Pohl | V. Dattola | R. Sandbrink | I. van den Elskamp | B. Boden